BridgeBio Oncology Therapeutics Inc. (BBOT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BridgeBio Oncology Therap...

    NASDAQ: BBOT · Real-Time Price · USD
    12.36
    -0.08 (-0.64%)
    At close: Oct 03, 2025, 3:59 PM
    12.60
    1.94%
    After-hours: Oct 03, 2025, 07:57 PM EDT

    BridgeBio Oncology Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.7M n/a n/a n/a
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 192.45M n/a n/a n/a
    Other Long-Term Assets
    		 25.13K 332.89K 144.58K 144.28K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a n/a n/a n/a
    Total Current Assets
    		 1.95M n/a n/a n/a
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 192.47M 332.89K 144.58K 144.28K
    Total Assets
    		 194.42M 332.89K 144.58K 144.28K
    Account Payables
    		 n/a n/a n/a n/a
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 70.09K 43.11K 36.96K
    Other Current Liabilities
    		 n/a n/a n/a n/a
    Total Current Liabilities
    		 187.51K 396.46K 166.46K 162.64K
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 5.52M n/a n/a n/a
    Total Long-Term Liabilities
    		 5.52M n/a n/a n/a
    Total Liabilities
    		 5.71M 396.46K 166.46K 162.64K
    Total Debt
    		 n/a 70.09K 43.11K 36.96K
    Book Value
    		 188.72M -63.57K -21.88K -18.36K
    Book Value Per Share
    		 11.34 -0.00 -0.00 -0.00
    Common Stock
    		 192.45M 460.00 288.00 288.00
    Retained Earnings
    		 -3.73M -88.57K -46.88K -43.36K
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 188.72M -63.57K -21.88K -18.36K
    Total Investments
    		 192.45M n/a n/a n/a

    Add to Watchlist